Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Mitobridge describes new ACMSD inhibitors

July 26, 2018

SSAO inhibitors identified at Ube Industries

July 25, 2018

Active substance in ROSgard protects kidney tissue in preclinical acute kidney injury study

July 24, 2018

Reata reports promising phase II data from bardoxolone trials in chronic kidney disease

July 24, 2018

Bridge Medicines and Memorial Sloan Kettering partner on platform to deliver drugs to kidneys

July 24, 2018

Kissei Pharmaceutical synthesizes new TRPM8 antagonists

July 19, 2018

Novel CD-1db/db mouse model of type 2 diabetes with progressive kidney fibrosis

July 18, 2018

Phase III CREDENCE trial of Invokana stopped early due to promising outcomes

July 17, 2018

Novel surgically induced rat model of diabetic nephropathy

July 13, 2018

Advicenne reports preliminary phase III extension study results for ADV-7103

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...